The findings by Zeltz and coworkers in lung adenocarcinoma and by us in cSCC demonstrate a link between α11 and ECM crosslinking by LOX and LOXL enzymes but also imply that the molecular mechanisms whereby α11β1 reorganizes the ECM vary by tumor and CAF subtype. This evidence concerns the gene LOXL3 and lung adenocarcinoma.